157 related articles for article (PubMed ID: 8279569)
21. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.
Matozaki T; Martinez J; Williams JA
Am J Physiol; 1989 Oct; 257(4 Pt 1):G594-600. PubMed ID: 2478032
[TBL] [Abstract][Full Text] [Related]
22. Pancreas growth, tyrosine kinase, PtdIns 3-kinase, and PLD involve high-affinity CCK-receptor occupation.
Rivard N; Rydzewska G; Lods JS; Martinez J; Morisset J
Am J Physiol; 1994 Jan; 266(1 Pt 1):G62-70. PubMed ID: 8304459
[TBL] [Abstract][Full Text] [Related]
23. Direct trophic effects of fibroblast growth factors on rat pancreatic acinar cells in vitro.
Hoshi H; Logsdon CD
Biochem Biophys Res Commun; 1993 Nov; 196(3):1202-7. PubMed ID: 7504468
[TBL] [Abstract][Full Text] [Related]
24. Cholecystokinin-induced formation of inositol phosphates in pancreatic acini.
Rowley WH; Sato S; Huang SC; Collado-Escobar DM; Beaven MA; Wang LH; Martinez J; Gardner JD; Jensen RT
Am J Physiol; 1990 Oct; 259(4 Pt 1):G655-65. PubMed ID: 1699431
[TBL] [Abstract][Full Text] [Related]
25. Effects of phospholipase A2 inhibitors on Ca2+ oscillations in pancreatic acinar cells.
Mizuno N; Naruse S; Kitagawa M; Ishiguro H; Hayakawa T
Pancreas; 2000 Jan; 20(1):77-83. PubMed ID: 10630387
[TBL] [Abstract][Full Text] [Related]
26. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
Taniguchi H; Nagasaki M; Tamaki H
Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
[TBL] [Abstract][Full Text] [Related]
27. CCK-JMV-180, an analog of cholecystokinin, releases intracellular calcium from an inositol trisphosphate-independent pool in rat pancreatic acini.
Saluja AK; Dawra RK; Lerch MM; Steer ML
J Biol Chem; 1992 Jun; 267(16):11202-7. PubMed ID: 1375937
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites.
Moran TH; Kornbluh R; Moore K; Schwartz GJ
Regul Pept; 1994 Aug; 52(3):165-72. PubMed ID: 7800848
[TBL] [Abstract][Full Text] [Related]
30. Structural requirements of CCK analogues to differentiate second messengers and pancreatic secretion.
Tsunoda Y; Yoshida H; Owyang C
Am J Physiol; 1996 Jul; 271(1 Pt 1):G8-19. PubMed ID: 8760101
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro.
Logsdon CD
Am J Physiol; 1986 Oct; 251(4 Pt 1):G487-94. PubMed ID: 3020992
[TBL] [Abstract][Full Text] [Related]
32. Species differences between rat and mouse CCKA receptors determine the divergent acinar cell response to the cholecystokinin analog JMV-180.
Ji B; Kopin AS; Logsdon CD
J Biol Chem; 2000 Jun; 275(25):19115-20. PubMed ID: 10748042
[TBL] [Abstract][Full Text] [Related]
33. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
Bianchi BR; Miller TR; Witte DG; Lin CW
J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
[TBL] [Abstract][Full Text] [Related]
34. CCK, bombesin, and carbachol stimulate c-fos, c-jun, and c-myc oncogene expression in rat pancreatic acini.
Lu L; Logsdon CD
Am J Physiol; 1992 Sep; 263(3 Pt 1):G327-32. PubMed ID: 1415544
[TBL] [Abstract][Full Text] [Related]
35. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells.
Witte DG; Nadzan AM; Martinez J; Rodriguez M; Lin CW
Peptides; 1992; 13(6):1227-32. PubMed ID: 1337381
[TBL] [Abstract][Full Text] [Related]
37. High- and low-affinity CCKA receptor states mediate specific growth inhibitory effects on CHO cells.
Detjen K; Tseng MJ; Logsdon CD
Biochem Biophys Res Commun; 1995 Aug; 213(1):44-51. PubMed ID: 7639760
[TBL] [Abstract][Full Text] [Related]
38. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion.
Saluja AK; Saluja M; Printz H; Zavertnik A; Sengupta A; Steer ML
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8968-71. PubMed ID: 2479032
[TBL] [Abstract][Full Text] [Related]
39. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low affinity CCK receptors.
Menozzi D; Stark HA; Martinez J; Jensen RT; Gardner JD
Peptides; 1989; 10(2):337-41. PubMed ID: 2474153
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C activation inhibits receptor-evoked inositol trisphosphate formation and induction of cytosolic calcium oscillations by decreasing the affinity-state of the cholecystokinin receptor in pancreatic acinar cells.
Willems PH; Smeets RL; Bosch RR; Garner KM; Van Mackelenbergh MG; De Pont JJ
Cell Calcium; 1995 Dec; 18(6):471-83. PubMed ID: 8746946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
